New FDA-Approved Diabetes Medicine Might Save Drugmaker
The U.S. Food and Drug Administration approved new diabetes drug Toujeo on Wednesday, a move that might save French drugmaker Sanofi's profits.By Christine Slusser | February 26, 2015
A new diabetes drug was approved by the Food and Drug Administration Wednesday. It doesn't sound like breaking news, but for the company behind the drug, it's a pretty big deal.
The French drugmaker Sanofi is now able to sell its drug Toujeo in the United States. And Sanofi is likely thanking its lucky stars.
The Wall Street Journal described it as a "crucial launch" for Sanofi as it struggles "to keep a firm grip on the all-important diabetes market."